BIRC5 and lung carcinoma: In addition, expression analysis in cancer tissues showed that NEK4 and survivin were elevated in tumor tissues compared to tumor-adjacent normal tissues (six of eight lung cancer patients and three of five colon cancer patients) (Figure 6).